The organization’s bi-annual study found that average billing rates increased by 7% in 2025. Average billing rates have ...

Nearly four in five marketing leaders (78 per cent) say earned media is now more effective than traditional advertising when ...

Bristol Myers Squibb has appointed Wendy Bartie as EVP, corporate affairs. Bartie started in the role this month, BMS said on ...

The health equity initiative marks an extension of Havas’ Meaningful Marketplaces, aiming to connect pharma and health companies with data and tools to better reach underserved populations across ...

Abcuro appointed former Priovant Therapeutics exec Courtney Cupples as chief commercial officer. Innospera Pharma appointed ...

Responding to charges that President Donald Trump’s tax and spending bill would cut Medicaid coverage for millions of ...

Building upon its efforts to expand consumer marketing beyond the traditional, Insulet designed a superhero comic to ...

Healthcare agencies lag behind the broader adland when it comes to workforce and leadership diversity. An MM+M analysis of ...

Since McKinney Health burst onto the scene in 2022, it has been carving out its place at the intersection of health and life.

In a world of slow-moving giants and siloed thinking, Spectrum Science is breaking the mold.

RayzeBio, the radiopharmaceutical unit of Bristol Myers Squibb, licensed an experimental drug and diagnostic agent for prostate cancer from Philochem AG for a $350 million upfront payment. Philochem ...

After firing the former members of ACIP earlier this week, Kennedy has appointed eight new members to the vaccine advisory board – including some vaccine skeptics.